EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Iridium Nanoparticle-Gated Janus Nanomachines for Enzyme-Controlled Drug Delivery

Beatriz Mayol, Marta González-Jiménez, Alfredo Sánchez, Susana Portela, Sandra Pradana-López, Carolina López-Benet, Teresa Moreno, RuiYuan Cai, Paloma Martínez-Ruiz, Narcisa Martínez-Quiles, Paula Díez, Ramón Martínez-Máñez und 3 weitere

ACS Applied Nano Materials · 14.08.2026 · 9 (32) · 15147-15160

DOI: 10.1021/acsanm.6c01043 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Nano Materials, online erschienen am 03.08.2026. Verfasst von Beatriz Mayol und 14 weiteren Autor:innen. Beteiligte Einrichtung: Nanosensors and Nanomachines Group, Department of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, Madrid 28040, Spain. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, Comunidad de Madrid, Universidad Complutense de Madrid.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Controlled drug delivery systems (DDSs) have emerged as a promising alternative to conventional therapies, aiming to optimize drug release profiles and improve therapeutic outcomes while reducing systemic side effects. In this work, iridium-gated Janus nanomachines are proposed as enzyme-regulated platforms for smart and autonomous drug delivery. These hybrid nanostructures consist of mesoporous silica nanoparticles asymmetrically functionalized with gold nanoparticles bearing surface-anchored enzymes on the metallic hemisphere, while the opposite mesoporous face incorporates pH-responsive molecular gates based on aminophenylboronic acid and d-lactose-functionalized iridium nanoparticles, enabling efficient cargo loading and motility behavior. To evaluate nanomachine operation, two enzymatic systems were employed: glucose oxidase (GOx) and a tandem esterase/alcohol oxidase (AOX) system, using spectrophotometric monitoring of the model cargo release. Both platforms exhibited well-defined release kinetics and good correlation between substrate concentration and high selectivity toward their respective inputs. Motility studies revealed the appearance of two particle populations in the presence of glucose or methanol, consistent with enhanced motion driven by catalytic reactions at the iridium nanoparticle surface upon enzymatic hydrogen peroxide generation. Finally, the GOx-based nanomachine loaded with the antitumoral drug doxorubicin (DOXO) demonstrated efficient cellular internalization, preserved biocompatibility, and enhanced antitumoral activity in HeLa cells. Overall, this work reinforces the potential of enzyme-controlled Janus nanomachines as multifunctional platforms integrating autonomous motion and stimulus-responsive drug delivery for advanced therapeutic applications.

Schlagwörter

Stichwörter der Autor:innen

Janus-nanoparticlesdrug delivery systemsenzymesnanomachinesnanorobots

Autor:innen und Institutionen

  • Nanosensors and Nanomachines Group, Department of Analytical Chemistry, Faculty of Chemistry, Complutense University of Madrid, Madrid 28040, Spain.
  • Department of Electrical and Computer Engineering, Rice University, Houston, Texas 77005, United States.
  • Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Camino de Vera, s/n., València 46022, Spain.
  • Unidad Mixta de Investigación En Nanomedicina y Sensores, Universitat Politècnica de València, Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia 46026, Spain.
  • Department of Immunology, Ophthalmology and ENT, School of Medicine, Complutense University, Madrid 28040, Spain.
  • CIBER de Bioingeniería, Biomateriales y Nanomedicina, Instituto de Salud Carlos III, Bellaterra 08913, Spain.

ORCID-Profile: Irene Ojeda, Diana Vilela, Reynaldo Villalonga

Förderung

  • European Research Council
  • Comunidad de Madrid
  • Universidad Complutense de Madrid
  • Ministerio de Economía y Competitividad
  • Universitat Politècnica de València
  • Ministerio de Educación, Cultura y Deporte
  • NextGenerationEU
  • Instituto de Salud Carlos III

Zitieren

APA

Mayol, B., González-Jiménez, M., Sánchez, A., Portela, S., Pradana-López, S., López-Benet, C., Moreno, T., Cai, R., Martínez-Ruiz, P., Martínez-Quiles, N., Díez, P., Martínez-Máñez, R., Ojeda, I., Vilela, D., & Villalonga, R. (2026). Iridium Nanoparticle-Gated Janus Nanomachines for Enzyme-Controlled Drug Delivery. ACS Applied Nano Materials, 9(32), 15147-15160. https://doi.org/10.1021/acsanm.6c01043

Vancouver

Mayol B, González-Jiménez M, Sánchez A, Portela S, Pradana-López S, López-Benet C, et al. Iridium Nanoparticle-Gated Janus Nanomachines for Enzyme-Controlled Drug Delivery. ACS Applied Nano Materials. 2026;9(32):15147-15160. doi:10.1021/acsanm.6c01043

BibTeX
@article{Mayol2026,
  author = {Mayol, Beatriz and González-Jiménez, Marta and Sánchez, Alfredo and Portela, Susana and Pradana-López, Sandra and López-Benet, Carolina and Moreno, Teresa and Cai, RuiYuan and Martínez-Ruiz, Paloma and Martínez-Quiles, Narcisa and Díez, Paula and Martínez-Máñez, Ramón and Ojeda, Irene and Vilela, Diana and Villalonga, Reynaldo},
  title = {Iridium Nanoparticle-Gated Janus Nanomachines for Enzyme-Controlled Drug Delivery},
  journal = {ACS Applied Nano Materials},
  year = {2026},
  volume = {9},
  number = {32},
  pages = {15147--15160},
  doi = {10.1021/acsanm.6c01043}
}
Kostenlos starten →